Jeffrey L. Alvaro, M.D., introduces an upcoming panel discussion surrounding the clinical implications of novel drug delivery systems in the management of Pediatric ADHD, utilizing 3 patient cases.
Jeffrey L Alvaro, MD
Advertisement
Articles by Jeffrey L Alvaro, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves first treatment for thymidine kinase 2 deficiency
2
J&J submits sBLA for ustekinumab to treat children with ulcerative colitis 2 years and up
3
FDA news in pediatrics: October 2025
4
Top 5 pediatric health headlines you missed in October 2025
5
